127 related articles for article (PubMed ID: 7546429)
1. Sorivudine (BV-ara-U) for the treatment of complicated refractory varicella zoster virus infection in HIV-infected patients.
Burdge DR; Voigt R; Lindley JI; Gage L; Sacks SL
AIDS; 1995 Jul; 9(7):810-2. PubMed ID: 7546429
[No Abstract] [Full Text] [Related]
2. Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir, and sorivudine.
Wunderli W; Miner R; Wintsch J; von Gunten S; Hirsch HH; Hirschel B
Clin Infect Dis; 1996 May; 22(5):864-5. PubMed ID: 8722954
[No Abstract] [Full Text] [Related]
3. Treatment of adult varicella with sorivudine: a randomized, placebo-controlled trial.
Wallace MR; Chamberlin CJ; Sawyer MH; Arvin AM; Harkins J; LaRocco A; Colopy MW; Bowler WA; Oldfield EC
J Infect Dis; 1996 Aug; 174(2):249-55. PubMed ID: 8699051
[TBL] [Abstract][Full Text] [Related]
4. Failure of sorivudine therapy in progressive outer retinal necrosis caused by varicella zoster virus.
Rosenthal G; Bartz-Schmidt KU; Walter P; Kirchhof B; Heimann K
Aust N Z J Ophthalmol; 1998 Nov; 26(4):327-8. PubMed ID: 9843261
[TBL] [Abstract][Full Text] [Related]
5. Treatment of progressive outer retinal necrosis with sorivudine.
Pinnolis MK; Foxworthy D; Kemp B
Am J Ophthalmol; 1995 Apr; 119(4):516-7. PubMed ID: 7709980
[TBL] [Abstract][Full Text] [Related]
6. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group.
Gnann JW; Crumpacker CS; Lalezari JP; Smith JA; Tyring SK; Baum KF; Borucki MJ; Joseph WP; Mertz GJ; Steigbigel RT; Cloud GA; Soong SJ; Sherrill LC; DeHertogh DA; Whitley RJ
Antimicrob Agents Chemother; 1998 May; 42(5):1139-45. PubMed ID: 9593141
[TBL] [Abstract][Full Text] [Related]
7. Clinical effect of BV-araU on varicella-zoster virus infection in immunocompromised patients with haematological malignancies.
Hiraoka A; Masaoka T; Nagai K; Horiuchi A; Kanamaru A; Niimura M; Hamada T; Takahashi M
J Antimicrob Chemother; 1991 Mar; 27(3):361-7. PubMed ID: 1645332
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of VZV infections in patients with HIV.
Gershon AA
Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
[TBL] [Abstract][Full Text] [Related]
9. Oral bioavailability and anti-simian varicella virus efficacy of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in monkeys.
Soike K; Huang JL; Tu JI; Stouffer B; Mitroka JG; Swerdel M; Olsen S; Bonner DP; Tuomari AV; Field AK
J Infect Dis; 1992 Apr; 165(4):732-6. PubMed ID: 1313071
[TBL] [Abstract][Full Text] [Related]
10. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella.
Sawyer MH; Wu YN; Chamberlin CJ; Burgos C; Brodine SK; Bowler WA; LaRocco A; Oldfield EC; Wallace MR
J Infect Dis; 1992 Oct; 166(4):885-8. PubMed ID: 1326584
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group.
Bodsworth NJ; Boag F; Burdge D; Généreux M; Borleffs JC; Evans BA; Modai J; Colebunders R; Thomas M; DeHertogh D; Pacelli L; Thomis J
J Infect Dis; 1997 Jul; 176(1):103-11. PubMed ID: 9207355
[TBL] [Abstract][Full Text] [Related]
13. Sorivudine: a promising drug for the treatment of varicella-zoster virus infection.
Whitley RJ
Neurology; 1995 Dec; 45(12 Suppl 8):S73-5. PubMed ID: 8545030
[TBL] [Abstract][Full Text] [Related]
14. Investigation of antiviral activity of 1-beta-D-arabinofuranosylthymine (ara-T) and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-ara-U) in monkeys infected with simian varicella virus.
Soike KF; Baskin G; Cantrell C; Gerone P
Antiviral Res; 1984 Oct; 4(5):245-57. PubMed ID: 6097178
[TBL] [Abstract][Full Text] [Related]
15. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
16. Sorivudine: a potent inhibitor of varicella zoster virus replication.
Whitley RJ
Adv Exp Med Biol; 1996; 394():41-4. PubMed ID: 8815706
[TBL] [Abstract][Full Text] [Related]
17. [Pneumonitis associated with primary infection by varicella-zoster virus: apropos of 11 cases].
Barreiro García PM; Pintor Holguín E; Burón Fernández MR; Díaz Pollán B; Roca Arbonés V
An Med Interna; 1999 Apr; 16(4):209-10. PubMed ID: 10339855
[No Abstract] [Full Text] [Related]
18. Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeys.
Soike KF; Cantrell C; Gerone PJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):20-5. PubMed ID: 3729332
[TBL] [Abstract][Full Text] [Related]
19. Complications of Varicella Zoster Infection of the Central Nervous System.
Thomas AS; Perez JA
Methodist Debakey Cardiovasc J; 2017; 13(2):76-77. PubMed ID: 28740587
[No Abstract] [Full Text] [Related]
20. Successors to acyclovir.
Easterbrook P; Wood MJ
J Antimicrob Chemother; 1994 Sep; 34(3):307-11. PubMed ID: 7829405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
